Dark

Check out our Level2View

FNA
Paragon 28, Inc.
stock NYSE

Inactive

Apr 17, 2025

13.09USD0.000%(0.00)19,382,860

Pre-market

0.00USD-100.000%(-13.09)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 12, 2022

07:12AM EST Paragon 28 Announces Acquisition Of Disior For $18M At Closing And Potential Future Payments Up To $8M Benzinga

07:00AM EST Paragon 28 Announces Acquisition of Disior Business Wire

Jan 10, 2022

06:11AM EST Paragon 28 Sees Q4 Sales $42.3M-$42.7M Vs. $38.37M Est., FY21 Sales $147M-$147.4M Vs. $143.06M Est. Benzinga

06:10AM EST Paragon 28 Sees Q4 Preliminary Revenue To Be In Range Of $42.3 To $42.7 Mln RTTNews

06:00AM EST Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2021 Business Wire

Dec 29, 2021

07:06AM EST Paragon 28: FDA Gives 501(k) Marketing Clearance To R3ACT(tm) Stabilization System RTTNews

07:04AM EST Paragon 28 R3ACT Stabilization System Cleared By FDA Benzinga

07:00AM EST Paragon 28, Inc. R3ACT(tm) Stabilization System Cleared by FDA Business Wire

Dec 16, 2021

07:00AM EST Paragon 28 to Present at 24th Annual Needham Growth Conference Business Wire

Dec 13, 2021

04:01PM EST Paragon 28's Patient Specific Titanium Talus Spacer Has Been Approved by the U.S. Food and Drug Administration Business Wire

Dec 1, 2021

07:00AM EST Paragon 28 Announces Addition of B. Kristine Johnson and Kristina Wright to its Board of Directors Business Wire

Nov 22, 2021

08:15AM EST Paragon 28 Q3 Net Revenue $35.9 Mln Up 18% From Last Year RTTNews

08:05AM EST Paragon 28 Sees Q4 2021 Revenue $38M-$39M Vs $37.39M Est Benzinga

08:05AM EST Paragon 28 Reports Q3 2021 Net Revenue $35.851M Vs $30.268M YoY; EPS $(0.12) Vs $0.06 YoY Benzinga

08:01AM EST Paragon 28 to Present at Piper Sandler 33rd Annual Healthcare Conference Business Wire

08:00AM EST Paragon 28 Reports Third Quarter 2021 Financial Results and Provides 2021 Fourth Quarter Net Revenue Guidance Business Wire

Nov 15, 2021

05:25PM EST Paragon 28 Receives FDA 501(k) Marketing Clearance For Its Circular External Fixation System Benzinga

04:13PM EST Paragon 28, Inc. Circular External Fixation System Cleared by FDA Business Wire

Nov 10, 2021

04:05PM EST Paragon 28 To Report Third Quarter 2021 Financial Results on November 22, 2021 Business Wire

Nov 9, 2021

12:02PM EST Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2021 Benzinga

11:31AM EST JMP Securities Initiates Coverage On Paragon 28 with Market Outperform Rating, Announces Price Target of $30 Benzinga

11:29AM EST Canaccord Genuity Initiates Coverage On Paragon 28 with Buy Rating, Announces Price Target of $28 Benzinga

11:28AM EST Piper Sandler Initiates Coverage On Paragon 28 with Overweight Rating, Announces Price Target of $30 Benzinga

11:25AM EST Needham Initiates Coverage On Paragon 28 with Buy Rating, Announces Price Target of $31 Benzinga

Oct 15, 2021

05:53PM EDT Paragon 28, Inc. Announces Pricing of Initial Public Offering PR Newswire

10:46AM EDT Paragon 28 Shares Open For Trade At $19.15; IPO Priced $16/Share Benzinga

09:43AM EDT Paragon 28 Shares Expected To Open For Quote Today; IPO Priced $16/Share Benzinga

12:00AM EDT Paragon 28 Announces Pricing Of IPO Of 7.81 Mln Shares At $16/Shr For $125.0 Mln RTTNews

Oct 14, 2021

10:35PM EDT Paragon 28, Inc. Announces Pricing of Initial Public Offering Business Wire

Share